Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
13.52
+0.64 (4.97%)
At close: Sep 4, 2025, 4:00 PM
13.30
-0.22 (-1.63%)
After-hours: Sep 4, 2025, 4:24 PM EDT

Mesoblast Statistics

Total Valuation

Mesoblast has a market cap or net worth of $1.66 billion. The enterprise value is $1.62 billion.

Market Cap1.66B
Enterprise Value 1.62B

Important Dates

The last earnings date was Thursday, August 28, 2025, after market close.

Earnings Date Aug 28, 2025
Ex-Dividend Date n/a

Share Statistics

Mesoblast has 1.28 billion shares outstanding. The number of shares has increased by 22.41% in one year.

Current Share Class n/a
Shares Outstanding 1.28B
Shares Change (YoY) +22.41%
Shares Change (QoQ) +11.47%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 787.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 96.36
Forward PS n/a
PB Ratio 2.77
P/TBV Ratio 64.70
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 94.44
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.21.

Current Ratio 1.99
Quick Ratio 1.72
Debt / Equity 0.21
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.87

Financial Efficiency

Return on equity (ROE) is -18.95% and return on invested capital (ROIC) is -5.89%.

Return on Equity (ROE) -18.95%
Return on Assets (ROA) -5.37%
Return on Invested Capital (ROIC) -5.89%
Return on Capital Employed (ROCE) -9.16%
Revenue Per Employee $235,589
Profits Per Employee -$1.40M
Employee Count73
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

In the past 12 months, Mesoblast has paid $330,000 in taxes.

Income Tax 330,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +94.53% in the last 52 weeks. The beta is 1.32, so Mesoblast's price volatility has been higher than the market average.

Beta (5Y) 1.32
52-Week Price Change +94.53%
50-Day Moving Average 13.94
200-Day Moving Average 13.74
Relative Strength Index (RSI) 40.95
Average Volume (20 Days) 188,793

Short Selling Information

Short Interest 2.38M
Short Previous Month 2.38M
Short % of Shares Out 2.35%
Short % of Float n/a
Short Ratio (days to cover) 8.87

Income Statement

In the last 12 months, Mesoblast had revenue of $17.20 million and -$102.14 million in losses. Loss per share was -$0.08.

Revenue17.20M
Gross Profit -22.74M
Operating Income -62.44M
Pretax Income -73.25M
Net Income -102.14M
EBITDA -58.18M
EBIT -62.44M
Loss Per Share -$0.08
Full Income Statement

Balance Sheet

The company has $161.55 million in cash and $128.16 million in debt, giving a net cash position of $33.39 million or $0.03 per share.

Cash & Cash Equivalents 161.55M
Total Debt 128.16M
Net Cash 33.39M
Net Cash Per Share $0.03
Equity (Book Value) 597.44M
Book Value Per Share 0.47
Working Capital 101.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$49.95 million and capital expenditures -$680,000, giving a free cash flow of -$50.63 million.

Operating Cash Flow -49.95M
Capital Expenditures -680,000
Free Cash Flow -50.63M
FCF Per Share -$0.04
Full Cash Flow Statement

Margins

Gross Margin -132.22%
Operating Margin -363.08%
Pretax Margin -592.00%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Mesoblast does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.41%
Shareholder Yield -22.41%
Earnings Yield -6.16%
FCF Yield -3.06%

Analyst Forecast

The average price target for Mesoblast is $18.00, which is 33.14% higher than the current price. The consensus rating is "Buy".

Price Target $18.00
Price Target Difference 33.14%
Analyst Consensus Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 126.79%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on January 10, 2024. It was a reverse split with a ratio of 1:2.

Last Split Date Jan 10, 2024
Split Type Reverse
Split Ratio 1:2

Scores

Mesoblast has an Altman Z-Score of 2.45 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.45
Piotroski F-Score 5